N/A
N=33
Immune Response After Booster Vaccination in HIV - Infected Patients Who Received Rabies Primary Vaccination
HIV · Rabies
Bottom Line
View on ClinicalTrials.gov: NCT01286493 ↗Enrolled (actual)
33
Serious AEs
0.0%
Results posted
Jun 2014
Primary outcome: Primary: Rabies Neutralizing Antibody Titers — 8.48 IU/ml
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- rabies vaccines on day 0 and 3 (Biological)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Queen Saovabha Memorial Institute
- Primary completion
- Dec 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rabies Neutralizing Antibody Titers |
8.48 | — |
Summary
Booster rabies vaccination in HIV - infected patients who have ever received rabies primary vaccination could improve their immune response to this kind of vaccine.
Eligibility Criteria
Inclusion Criteria
- HIV infected patients 18-60 years of age
- Ever received primary rabies immunization
Exclusion Criteria
- currently have any active opportunistic infections
- have received blood or blood product within previous 3 months
- history of allergy to vaccine or any vaccine components
- currently received anti-malarial drugs
Data sourced from ClinicalTrials.gov (NCT01286493). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.